Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study

MLA

de la Court, Jara R., et al. “Third-Generation Cephalosporin Resistant Gram-Negative Bacteraemia in Patients with Haematological Malignancy; an 11-Year Multi-Centre Retrospective Study.” Annals of Clinical Microbiology and Antimicrobials, vol. 21, Nov. 2022. EBSCOhost, https://doi.org/10.1186/s12941-022-00544-0.

APA

de la Court, J. R., Woudt, S. H. S., Schoffelen, A. F., Heijmans, J., de Jonge, N. A., van der Bruggen, T., Bomers, M. K., Lambregts, M. M. C., Schade, R. P., Sigaloff, K. C. E., Stuart, J. W. T. C., Melles, D. C., van Dijk, K., Alzubaidy, A., Werdmuller, B. F. M., Blaauw, G. J., Diederen, B. M. W., Alblas, H. J., der Kuil, W. A., … Wolfhagen, M. J. H. M. (2022). Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study. Annals of Clinical Microbiology and Antimicrobials, 21. https://doi.org/10.1186/s12941-022-00544-0

Chicago

de la Court, Jara R., Sjoukje H. S. Woudt, Annelot F. Schoffelen, Jarom Heijmans, Nick A. de Jonge, Tjomme van der Bruggen, Marije K. Bomers, et al. 2022. “Third-Generation Cephalosporin Resistant Gram-Negative Bacteraemia in Patients with Haematological Malignancy; an 11-Year Multi-Centre Retrospective Study.” Annals of Clinical Microbiology and Antimicrobials 21 (November). doi:10.1186/s12941-022-00544-0.